BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21174089)

  • 1. Molecular imaging of atherosclerosis in translational medicine.
    Perrone-Filardi P; Dellegrottaglie S; Rudd JH; Costanzo P; Marciano C; Vassallo E; Marsico F; Ruggiero D; Petretta MP; Chiariello M; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2011 May; 38(5):969-75. PubMed ID: 21174089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From myocardium to the atherosclerotic plaque: new perspectives in cardiologic imaging].
    Gargiulo P; D'Amore C; Dellegrottaglie S; Leosco D; Rengo G; Musella F; Pirozzi E; Mosca S; Casaretti L; Formisano R; Bologna A; Parente A; Conte S; Perrone-Filardi P
    Monaldi Arch Chest Dis; 2011 Jun; 76(2):60-5. PubMed ID: 22128608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI.
    Fernández-Friera L; Fuster V; López-Melgar B; Oliva B; Sánchez-González J; Macías A; Pérez-Asenjo B; Zamudio D; Alonso-Farto JC; España S; Mendiguren J; Bueno H; García-Ruiz JM; Ibañez B; Fernández-Ortiz A; Sanz J
    J Am Coll Cardiol; 2019 Apr; 73(12):1371-1382. PubMed ID: 30922468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging atherosclerosis in HIV: carotid intima-media thickness and beyond.
    Longenecker CT; Hoit BD
    Transl Res; 2012 Mar; 159(3):127-39. PubMed ID: 22340762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
    Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
    J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological validation of iron-oxide and gadolinium based MRI contrast agents in experimental atherosclerosis: the do's and don't's.
    den Adel B; Bovens SM; te Boekhorst B; Strijkers GJ; Poelmann RE; van der Weerd L; Pasterkamp G
    Atherosclerosis; 2012 Dec; 225(2):274-80. PubMed ID: 22882907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.
    Nörenberg D; Ebersberger HU; Diederichs G; Hamm B; Botnar RM; Makowski MR
    Eur Radiol; 2016 Mar; 26(3):910-20. PubMed ID: 26139316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular imaging of vascular inflammation.
    Tahara N; Tahara A; Honda A; Nitta Y; Kodama N; Yamagishi S; Imaizumi T
    Curr Pharm Des; 2014; 20(14):2439-47. PubMed ID: 23844819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary carotid imaging: from degree of stenosis to plaque vulnerability.
    Brinjikji W; Huston J; Rabinstein AA; Kim GM; Lerman A; Lanzino G
    J Neurosurg; 2016 Jan; 124(1):27-42. PubMed ID: 26230478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
    Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
    Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
    Magnoni M; Ammirati E; Camici PG
    J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.
    Pérez-Medina C; Binderup T; Lobatto ME; Tang J; Calcagno C; Giesen L; Wessel CH; Witjes J; Ishino S; Baxter S; Zhao Y; Ramachandran S; Eldib M; Sánchez-Gaytán BL; Robson PM; Bini J; Granada JF; Fish KM; Stroes ES; Duivenvoorden R; Tsimikas S; Lewis JS; Reiner T; Fuster V; Kjær A; Fisher EA; Fayad ZA; Mulder WJ
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):950-61. PubMed ID: 27236528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular imaging in cardiovascular diseases.
    Botnar RM; Ebersberger H; Noerenberg D; Jansen CH; Wiethoff AJ; Schuster A; Kasner M; Walter TC; Knobloch G; Hoppe P; Diederichs G; Hamm B; Makowski MR
    Rofo; 2015 Feb; 187(2):92-101. PubMed ID: 25585260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients.
    Tawakol A; Migrino RQ; Bashian GG; Bedri S; Vermylen D; Cury RC; Yates D; LaMuraglia GM; Furie K; Houser S; Gewirtz H; Muller JE; Brady TJ; Fischman AJ
    J Am Coll Cardiol; 2006 Nov; 48(9):1818-24. PubMed ID: 17084256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.
    Vazquez-Prada KX; Lam J; Kamato D; Xu ZP; Little PJ; Ta HT
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):601-613. PubMed ID: 33356385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Diagnostic Performances of Ultrasound, High-Resolution Magnetic Resonance Imaging, and Positron Emission Tomography/Computed Tomography in a Rabbit Carotid Vulnerable Plaque Atherosclerosis Model.
    Xu L; Wang R; Liu H; Wang J; Liang W; Mang J; Xu Z
    J Ultrasound Med; 2020 Nov; 39(11):2201-2209. PubMed ID: 32395879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R
    Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive cardiovascular imaging in rheumatoid arthritis: current modalities and the emerging role of magnetic resonance and positron emission tomography imaging.
    Furer V; Fayad ZA; Mani V; Calcagno C; Farkouh ME; Greenberg JD
    Semin Arthritis Rheum; 2012 Apr; 41(5):676-88. PubMed ID: 22000818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries.
    Okane K; Ibaraki M; Toyoshima H; Sugawara S; Takahashi K; Miura S; Shimosegawa E; Satomi J; Kitamura K; Satoh T
    Eur J Nucl Med Mol Imaging; 2006 May; 33(5):589-94. PubMed ID: 16491424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.